{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:32:13Z","timestamp":1790836333630,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.cgh.2016.08.047","type":"journal-article","created":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T18:32:53Z","timestamp":1481567573000},"page":"5-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["Medical Management of Severe Alcoholic Hepatitis: Expert\u00a0Review from the Clinical Practice Updates Committee of\u00a0the AGA Institute"],"prefix":"10.1016","volume":"15","author":[{"given":"Mack C.","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence S.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"McClain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2016.08.047_bib1","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/MCG.0000000000000161","article-title":"Translational Research and Evolving Alcoholic Hepatitis Treatment Consortium. Trends in alcoholic hepatitis-related hospitalizations, financial burden, and mortality in the United States","volume":"49","author":"Jinjuvadia","year":"2015","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2016.08.047_bib2","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/acer.13069","article-title":"The worsening profile of alcoholic hepatitis in the United States","volume":"40","author":"Nguyen","year":"2016","journal-title":"Alcohol Clin Exp Research"},{"key":"10.1016\/j.cgh.2016.08.047_bib3","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.27779","article-title":"Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis","volume":"62","author":"Michelena","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.08.047_bib4","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jhep.2011.02.021","article-title":"The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis","volume":"55","author":"Mookerjee","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2016.08.047_bib5","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/j.gastro.2014.01.018","article-title":"A\u00a0histologic scoring system for prognosis of patients with alcoholic hepatitis","volume":"146","author":"Altamirano","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.08.047_bib6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA Alcoholic Hepatitis Consortia","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.08.047_bib7","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1053\/j.gastro.2006.08.020","article-title":"Utility of a new model to diagnose an alcohol basis for steatohepatitis","volume":"131","author":"Dunn","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.08.047_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.08.047_bib9","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methylprednisolone therapy in patients with severe alcoholic hepatitis: a randomized multicenter trial","volume":"110","author":"Carithers","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2016.08.047_bib10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20503","article-title":"MELD accurately predicts mortality in patients with alcoholic hepatitis","volume":"41","author":"Dunn","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.08.047_bib11","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1111\/j.1572-0241.2008.02104.x","article-title":"A\u00a0new scoring system for prognostic stratification of patients with alcoholic hepatitis","volume":"103","author":"Dominguez","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.08.047_bib12","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1136\/gut.2006.099226","article-title":"The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids","volume":"56","author":"Forrest","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2016.08.047_bib13","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2016.08.047_bib14","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.08.047_bib15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1053\/j.gastro.2015.04.044","article-title":"Combining data from liver disease scoring systems better predicts outcomes of patients with alcoholic hepatitis","volume":"149","author":"Louvet","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.08.047_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1210\/me.2008-0283","article-title":"Minireview: latest perspectives on antiinflammatory actions of glucocorticoids","volume":"23","author":"De Bosscher","year":"2009","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.cgh.2016.08.047_bib17","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/S0140-6736(09)60326-3","article-title":"Glucocorticoid resistance in inflammatory diseases","volume":"373","author":"Barnes","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2016.08.047_bib18","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jaci.2006.01.032","article-title":"Update on glucocorticoid action and resistance","volume":"117","author":"Ito","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.cgh.2016.08.047_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.20050466","article-title":"Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression","volume":"203","author":"Ito","year":"2006","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cgh.2016.08.047_bib20","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/hep.24159","article-title":"In\u00a0vitro steroid resistance correlates with outcome in severe alcoholic hepatitis","volume":"53","author":"di Mambro","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.08.047_bib21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jsbmb.2010.02.018","article-title":"Mechanisms and resistance in glucocorticoid control of inflammation","volume":"120","author":"Barnes","year":"2010","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.cgh.2016.08.047_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0039.2006.00599.x","article-title":"Glucocorticoid modulation of cytokine signaling","volume":"68","author":"Rogatsky","year":"2006","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.cgh.2016.08.047_bib23","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1478-3231.2006.01419.x","article-title":"The effects of pentoxifylline on liver regeneration after portal vein ligation in rats","volume":"27","author":"Kucuktulu","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2016.08.047_bib24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/gut.50.2.241","article-title":"Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis","volume":"50","author":"Raetsch","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2016.08.047_bib25","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/bjp.2008.307","article-title":"PDE4 inhibitors: current status","volume":"155","author":"Spina","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cgh.2016.08.047_bib26","doi-asserted-by":"crossref","first-page":"G681","DOI":"10.1152\/ajpgi.00098.2006","article-title":"Chronic ethanol-mediated decrease in cAMP primes macrophages to enhanced LPS-inducible NF-kappaB activity and TNF expression: relevance to alcoholic liver disease","volume":"291","author":"Gobejishvili","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.cgh.2016.08.047_bib27","doi-asserted-by":"crossref","first-page":"G718","DOI":"10.1152\/ajpgi.90232.2008","article-title":"Enhanced PDE4B expression augments LPS-inducible TNF expression in ethanol-primed monocytes: relevance to alcoholic liver disease","volume":"295","author":"Gobejishvili","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.cgh.2016.08.047_bib28","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1067\/mai.2001.119555","article-title":"Cyclic nucleotide phosphodiesterases","volume":"108","author":"Essayan","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.cgh.2016.08.047_bib29","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s00011-005-1386-1","article-title":"The inhibitory effects of roflumilast on lipopolysaccharide-induced nitric oxide production in RAW264.7 cells are mediated by heme oxygenase-1 and its product carbon monoxide","volume":"54","author":"Kwak","year":"2005","journal-title":"Inflamm Res"},{"key":"10.1016\/j.cgh.2016.08.047_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pupt.2004.09.031","article-title":"The novel phosphodiesterase 4 inhibitor, CI-1044, inhibits LPS-induced TNF-alpha production in whole blood from COPD patients","volume":"18","author":"Ouagued","year":"2005","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.cgh.2016.08.047_bib31","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/hep.1840220516","article-title":"Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholics cirrhosis","volume":"22","author":"Le Moine","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.08.047_bib32","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1002\/(SICI)1521-4141(199910)29:10<3098::AID-IMMU3098>3.0.CO;2-H","article-title":"Cyclic adenosine monophosphate-responsive elements are involved in the transcriptional activation of the human IL-10 gene in monocytic cells","volume":"29","author":"Platzer","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cgh.2016.08.047_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jlb.63.1.101","article-title":"Anti-inflammatory activities of cAMP-elevating agents: enhancement of IL-10 synthesis and concurrent suppression of TNF production","volume":"63","author":"Eigler","year":"1998","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.cgh.2016.08.047_bib34","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0022-3565(25)24562-1","article-title":"Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors","volume":"272","author":"Verghese","year":"1995","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.cgh.2016.08.047_bib35","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.4049\/jimmunol.155.10.4909","article-title":"Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages","volume":"155","author":"Kambayashi","year":"1995","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cgh.2016.08.047_bib36","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1124\/jpet.113.204933","article-title":"Rolipram attenuates bile duct ligation-induced liver injury in rats: a potential pathogenic role of PDE4","volume":"347","author":"Gobejishvili","year":"2013","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.cgh.2016.08.047_bib37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000118897","article-title":"A\u00a0multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder","volume":"26","author":"Fleischhacker","year":"1992","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.cgh.2016.08.047_bib38","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1053\/gast.1996.v110.pm8964410","article-title":"Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone","volume":"110","author":"Mathurin","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.08.047_bib39","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data","volume":"60","author":"Mathurin","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2016.08.047_bib40","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1111\/j.1572-0241.1999.03065.x","article-title":"Glucocorticosteroids are not effective in alcoholic hepatitis","volume":"94","author":"Christensen","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.08.047_bib41","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1365-2036.2008.03685.x","article-title":"Systematic review: glucocorticosteroids for alcoholic hepatitis\u2014a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials","volume":"27","author":"Rambaldi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2016.08.047_bib42","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2013.276300","article-title":"Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial","volume":"310","author":"Mathurin","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2016.08.047_bib43","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM199202203260802","article-title":"A\u00a0randomized trial of prednisolone in patients with severe alcoholic hepatitis","volume":"326","author":"Ramond","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2016.08.047_bib44","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","article-title":"Alcoholic liver disease","volume":"51","author":"O'Shea","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.08.047_bib45","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2012.04.004","article-title":"EASL clinical practical guidelines: management of alcoholic liver disease","volume":"57","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2016.08.047_bib46","doi-asserted-by":"crossref","first-page":"299","DOI":"10.7326\/0003-4819-113-4-299","article-title":"Do corticosteroids reduce mortality from alcoholic hepatitis? a meta-analysis of the randomized trials","volume":"113","author":"Imperiale","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2016.08.047_bib47","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.08.047_bib48","first-page":"20","article-title":"Pentoxifylline in severe alcoholic hepatitis: a prospective, randomised trial","volume":"60","author":"Sidhu","year":"2012","journal-title":"J\u00a0Assoc Physicians India"},{"key":"10.1016\/j.cgh.2016.08.047_bib49","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3748\/wjg.15.1613","article-title":"Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial","volume":"15","author":"De","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.08.047_bib50","first-page":"CD007339","article-title":"Pentoxifylline for alcoholic hepatitis","author":"Whitfield","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2016.08.047_bib51","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/apt.12279","article-title":"Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitis","volume":"37","author":"Parker","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2016.08.047_bib52","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1007\/s10620-012-2097-4","article-title":"Corticosteroid plus pentoxifylline is not better than corticosteroid alone for improving survival in severe alcoholic hepatitis (COPE trial)","volume":"57","author":"Sidhu","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2016.08.047_bib53","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1053\/j.gastro.2015.06.006","article-title":"Comparative effectiveness of pharmacological interventions for severe alcoholic hepatitis: a systematic review and network meta-analysis","volume":"149","author":"Singh","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.08.047_bib54","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0168-8278(03)00476-8","article-title":"A\u00a0randomized placebo controlled trial of vitamin E for alcoholic hepatitis","volume":"40","author":"Mezey","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2016.08.047_bib55","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhep.2007.03.027","article-title":"A\u00a0randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis","volume":"47","author":"Stewart","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2016.08.047_bib56","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2016.08.047_bib57","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1530-0277.1990.tb00482.x","article-title":"Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis","volume":"14","author":"Felver","year":"1990","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cgh.2016.08.047_bib58","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.1840090302","article-title":"Increased tumor necrosis factor production by monocytes in alcoholic hepatitis","volume":"9","author":"McClain","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.08.047_bib59","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0168-8278(02)00230-1","article-title":"Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study","volume":"37","author":"Spahr","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2016.08.047_bib60","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1572-0241.2004.04034.x","article-title":"A\u00a0pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis","volume":"99","author":"Menon","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.08.047_bib61","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1053\/j.gastro.2008.08.057","article-title":"A\u00a0randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis","volume":"135","author":"Boetticher","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.08.047_bib62","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A\u00a0double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.08.047_bib63","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor","volume":"137","author":"Louvet","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.08.047_bib64","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cgh.2011.09.011","article-title":"Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis","volume":"10","author":"Altamirano","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2016.08.047_bib65","doi-asserted-by":"crossref","first-page":"895","DOI":"10.5604\/16652681.1171779","article-title":"Contrast-induced acute kidney injury in cirrhotic patients: a retrospective analysis","volume":"14","author":"Safi","year":"2015","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cgh.2016.08.047_bib66","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/0148607195019004258","article-title":"Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment\u2014the VA Cooperative Study Group #275","volume":"19","author":"Mendenhall","year":"1995","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.cgh.2016.08.047_bib67","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/jhep.2000.8627","article-title":"Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial","volume":"32","author":"Cabre","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.08.047_bib68","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.gastro.2015.12.038","article-title":"Intensive enteral nutrition is ineffective for patients with severe alcoholic hepatitis treated with corticosteroids","volume":"150","author":"Moreno","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.08.047_bib69","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/0884533611433534","article-title":"Zinc and liver disease","volume":"27","author":"Mohammad","year":"2012","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.cgh.2016.08.047_bib70","doi-asserted-by":"crossref","first-page":"5491465","DOI":"10.1155\/2016\/5491465","article-title":"Probiotics and alcoholic liver disease: treatment and potential mechanisms","volume":"2016","author":"Li","year":"2016","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.cgh.2016.08.047_bib71","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","article-title":"Early liver transplantation for severe alcoholic hepatitis","volume":"365","author":"Mathurin","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2016.08.047_bib72","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/TP.0000000000001156","article-title":"Liver transplantation for alcoholic liver disease","volume":"100","author":"Addolorato","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.cgh.2016.08.047_bib73","first-page":"210","article-title":"Prognostic factors in alcoholic liver disease: VA Cooperative Study Group","volume":"86","author":"Chedid","year":"1991","journal-title":"Am J Gastroenterol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356516307984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356516307984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:20:57Z","timestamp":1761542457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356516307984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1542356516307984"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2016.08.047","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical Management of Severe Alcoholic Hepatitis: Expert\u00a0Review from the Clinical Practice Updates Committee of\u00a0the AGA Institute","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2016.08.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the AGA Institute","name":"copyright","label":"Copyright"}]}}